Raymond James began new coverage on Franco-Nevada Corporation giving the company a "outperform" rating.
Several other analysts also recently issued reports on FNV. Van ECK Associates Corp now owns 10,773,637 shares of the basic materials company's stock valued at $705,781,000 after buying an additional 666,196 shares in the last quarter. As of the end of the quarter Fiera Capital Corp had acquired 277,080 shares growing its holdings by 33.5%. Capstone Asset Management Co. now owns 23,100 shares of the basic materials company's stock valued at $1,667,000 after buying an additional 120 shares during the last quarter. Franco-Nevada Corporation earned a news sentiment score of 0.31 on Accern's scale. Vanguard Group Inc. increased its stake in Franco-Nevada Corporation by 4.9% in the first quarter. Chase Investment Counsel Corp now owns 4,365 shares of the basic materials company's stock valued at $314,000 after buying an additional 305 shares during the last quarter. Finally, Gluskin Sheff & Assoc Inc. purchased a new position in Franco-Nevada Corporation during the first quarter worth $225,000.
For this year, Franco-Nevada Corporation (NYSE:FNV) is performing 26%.
The P/E ratio is now 99.50 and the market cap is 14.16B.
The stock is trading at $77.66 significantly above the 50 day moving average which is $72.65 and quite a bit above the 200 day moving average of $69.09. Franco-Nevada Corporation has a 52 week low of $53.31 and a 52 week high of $80.00. (NYSE:FNV) shares saw light trading volume with 1,010K shares changing hands in the last trading session. The Company has 178.63 million shares outstanding while EPS in next five years is expected to reach 5% while EPS growth in past 5 year was -7.42%. The company had revenue of $163.60 million during the quarter, compared to the consensus estimate of $164.62 million. Franco-Nevada Corporation had a return on equity of 4.35% and a net margin of 21.17%. The business's revenue was up 8.8% compared to the same quarter previous year.
Analysts expect Ra Pharmaceuticals Inc (NASDAQ:RARX) to report $-0.57 EPS on August, 10.After having $-0.50 EPS previously, Ra Pharmaceuticals Inc's analysts see 14.00% EPS growth. Franco-Nevada Corp had 32 analyst reports since August 11, 2015 according to SRatingsIntel.
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Stockholders of record on Thursday, September 14th will be issued a $0.23 dividend. The ex-dividend date was set for Tuesday the 13th of June 2017. This represents a $0.92 annualized dividend and a dividend yield of 1.18%.
TRADEMARK VIOLATION WARNING: This article was originally published by StockNewsTimes and is the sole property of of StockNewsTimes.
Relative Strength Index (RSI) for Franco-Nevada Corporation (FNV) is at 60.12. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & worldwide copyright and trademark laws. The legal version of this article can be accessed at https://theolympiareport.com/2017/08/11/national-bank-financial-comments-on-franco-nevada-corporations-q3-2017-earnings-nysefnv.html. Finally, Canaccord Genuity boosted their price objective on Franco Nevada Corp from C$111.00 to C$114.00 in a research report on Wednesday.
Franco-Nevada Corporation had its "hold" rating reiterated by analysts at Deutsche Bank. BidaskClub cut shares of Franco-Nevada Corporation from a "strong-buy" rating to a "buy" rating in a report on Wednesday, July 5th. Research firm Zacks lifted Franco-Nevada Corporation from a "hold" recommendation to a "buy" recommendation and fixed a $80.00 price objective on the shares in a note on Wed, Jul 12th. Nine research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company.
Analysts await Franco-Nevada Corporation (NASDAQ:FNV) to report earnings on Aug, 08 for the fiscal quarter ending Jun 2017. The Company has interests in silver, platinum group metals, oil and gas and other resource assets. The Firm is engaged in resource sector royalty/stream acquisitions and management activities.
Here are some other firms who have updated their holdings.